Organizers of the 31st annual Delta Symposium at Arkansas State University have issued a call for papers and presentations.

If you encounter problems during abstract submission, email meetings@esa.org. About Contributed Presentations. We invite submission of abstracts for individual contributed presentations for the 2023 ...

Preference for an oral or poster presentation . In recent years, the interest in presenting a contributed oral presentation has been much higher than presenting a contributed poster presentation.

MAIA Biotechnology, Inc.,, a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract about its Phase 2 THIO-101 clinical trial ...

Pyros Pharmaceuticals’ Abstract Accepted for Poster Presentation at the American Epilepsy Society (AES) 2024 Annual Meeting August 20, 2024 04:00 PM Eastern Daylight Time.

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference. PR Newswire. AUSTIN, Texas, April 28, 2025.

BioMimetix Announces Acceptance of Late-Breaking Abstract and Oral Presentation of BMX-001 Clinical Data at the 2023 Society for Neuro-Oncology Annual Meeting October 26, 2023 08:00 AM Eastern ...

Pharvaris, a biopharmaceutical company based in Zug, Switzerland, announced the acceptance of multiple abstracts for presentation at three significant upcoming congresses focusing on angioedema ...

LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today ...